Similar to new Hollywood feature Rampage, a recent study has urged the life sciences industry not to underestimate the dangers that could hide within CRISPR Cas9.
Drawing on experience of helping a wide range of life sciences companies with early submissions, Pooja Phogat, regulation and compliance expert at Kinapse, provides insight on the most effective approaches that reflect the spirit of the Policy
Human Genetics Scientist, Joyce El Hokayem examines where the digital era is taking today’s clinical trials.
Imagine a day where you don’t have to wait weeks to see your GP, followed by a further wait for medical test results and then still more waiting before being seen by a specialist
These pharma and medical podcasts allow you to digest the latest inspiring discoveries and developments in medicine and healthcare
Over 60% of you said quality of services was the most important criteria when selecting a CRO. Find out who the TOP 10 CROs are in the industry as voted by our members.
What exactly do pharmaceutical regulators around the world want to see? We take a look at the latest trends and real world findings so you can align yourselves with the tastes of compliance regulators.
The pharmaceutical industry is looking at its vast reserves of data for actionable insights to inform drug discovery.
Virtual clinical trials are here. Will they work? Todd Johnson of Halloran Consulting Group gives his insight as a participant of a virtual clinical trial.
As drug discovery continues its journey towards obtaining the optimal data lifecycle, Nigel Hughes discusses the lack of GDPR urgency that has been spotted and the needed quality boost for real world data.